The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Visipaque 320 mg I/ml Solution for Injection, polypropylene container

GE Healthcare ASPA0735/009/013

Main Information

Trade NameVisipaque 320 mg I/ml Solution for Injection, polypropylene container
Active SubstancesIodixanol
Dosage FormSolution for injection
Licence HolderGE Healthcare AS
Licence NumberPA0735/009/013

Group Information

ATC CodeV08AB Watersoluble, nephrotropic, low osmolar X-ray contrast media
V08AB09 iodixanol


License statusAuthorised
Licence Issued19/09/1995
Legal statusProduct subject to Restricted Prescription (C)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceRestricted to hospital dispensing
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back